These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24517245)

  • 1. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
    Schaffer JM; Chiu P; Singh SK; Oyer PE; Reitz BA; Mallidi HR
    Am J Transplant; 2014 Mar; 14(3):647-59. PubMed ID: 24517245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure.
    Schaffer JM; Chiu P; Singh SK; Oyer PE; Reitz BA; Mallidi HR
    Am J Transplant; 2014 Feb; 14(2):384-96. PubMed ID: 24279876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.
    Braun HJ; Perito ER; Dodge JL; Rhee S; Roberts JP
    Am J Transplant; 2016 Nov; 16(11):3181-3191. PubMed ID: 27214757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factors for Stroke After Combined Heart-Kidney and Heart-Liver Transplantation.
    Akbar AF; Rokui S; Zhou AL; Kilic A; King E; Cho SM
    Clin Transplant; 2024 Jun; 38(6):e15369. PubMed ID: 39031709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation.
    Kwong AJ; Schnellinger E; Foutz J; Cafarella M; Nagai S; Biggins SW; Pomposelli J; Trotter J
    Am J Transplant; 2024 Jun; 24(6):1080-1086. PubMed ID: 38408641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.
    Perito ER; Bucuvalas J; Lai JC
    Am J Transplant; 2019 May; 19(5):1388-1396. PubMed ID: 30506640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
    Swenson SM; Roberts JP; Rhee S; Perito ER
    Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
    Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exception Policy Change Increased the Simultaneous Kidney-Liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Miyake K; Kim DY; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Yoshida A; Abouljoud MS; Nagai S
    Transplantation; 2024 Jul; 108(7):1632-1640. PubMed ID: 38548699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
    Ross K; Patzer RE; Goldberg DS; Lynch RJ
    Am J Transplant; 2017 Nov; 17(11):2879-2889. PubMed ID: 28695615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.
    Sganga D; Hollander SA; Vaikunth S; Haeffele C; Bensen R; Navaratnam M; McDonald N; Profita E; Maeda K; Concepcion W; Bernstein D; Chen S
    J Heart Lung Transplant; 2021 Apr; 40(4):298-306. PubMed ID: 33485775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.